
GC32769
MRX-2843 (UNC2371)
Also known as 4-[2-(2-cyclopropylethylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol
MRX-2843 (UNC2371) (UNC2371) is an orally active, ATP-competitive dual MERTK and FLT3 tyrosine kinases inhibitor (TKI) with enzymatic IC50s of 1·3 nM for MERTK and 0·64 nM for FLT3, respectively
ChemicalCAS1429882-07-4MW488.67FormulaC29H40N6O
- CAS number
- 1429882-07-4
- Molecular weight
- 488.67
- Formula
- C29H40N6O
- Solubility
- DMSO : 31·25 mg/mL (63·95 mM)
- InChIKey
- LBEJYFVJIPQSNX-UHFFFAOYSA-N
- Catalogue number
- GC32769
- Brand
- GLPBIO
Computed properties PubChem CID 89495685 · XLogP 4.2 · TPSA 69.5 Ų · H-bond donors 2
- XLogP
- 4.2
- TPSA
- 69.5 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 8
- Heavy atoms
- 36
SMILES CN1CCN(CC1)CC2=CC=C(C=C2)C3=CN(C4=NC(=NC=C34)NCCC5CC5)C6CCC(CC6)O
Computed descriptors from PubChem (CID 89495685), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il